New evidence shows immunization against “swine flu” in 1976 might provide individuals with some protection against the 2009 pandemic H1N1 influenza virus, according to new research from St. Jude investigators. Researchers found that individuals who reported receiving the 1976 vaccine mounted an enhanced immune response against both the 2009 pandemic H1N1 virus and a different [...]
Apr 25 2010 | Posted in
Health |
Read More »
Lethality of H1N1 Virus Drops to “Non-Epidemic Resting Levels” in Current Cycle – Virus’ Infectivity Remains Increased; New Faster-Developed Synthetic Replikin Vaccines Found Effective, FluForecast(R) Gives Advance Warning of Strain-Specific Outbreaks and Cessation Biotech firm Replikins Ltd., which has analyzed the H1N1 virus’ genomic data from the 1918 pandemic through the prediction, outbreak, and progress [...]
Nov 28 2009 | Posted in
General,
Health,
U.S. |
Read More »
Both Live, Attenuated Influenza Vaccine (LAIV) and Trivalent Inactivated Vaccine (TIV) provide Protection against novel A/H1N1, especially against severe disease Immunization with either live attenuated influenza vaccine (LAIV, also known as FluMist®), or trivalent inactivated influenza vaccine (TIV), appears to offer a protection (~ 45%) against the novel A/H1N1 virus, the cause of the present [...]
Nov 21 2009 | Posted in
General,
Health,
U.S. |
Read More »
According to the Centers for Disease Control and Prevention (CDC), 37 states in the U.S. now report widespread influenza activity – and nearly all influenza cases reported to the health authority are 2009 H1N1, also known as swine flu. However, with the release of a 2009 H1N1 vaccine this week, parents have a new preventative [...]
Oct 16 2009 | Posted in
General,
Health,
U.S. |
Read More »
Approximately 100,000 doses can be manufactured per week Protein Sciences Corporation (PSC) announced that it commenced manufacturing of a vaccine to protect humans against the H1N1 “swine flu” virus. The Company estimates that it can produce 100,000 doses this week and at least 100,000 doses per week thereafter. The vaccine, called PanBlok(R), is made using [...]
Jun 16 2009 | Posted in
General,
Health,
U.S. |
Read More »
AVAC Report Assesses Progress in AIDS Vaccine, Microbicide and PrEP Research and Calls for Urgent Coordination and Leadership in Advance of Upcoming Results “It’s an exciting time in HIV prevention research. We will see results from a number of critically important HIV prevention research trials this year, as well as see the start of new [...]
May 19 2009 | Posted in
General,
Health,
U.S. |
Read More »
A synthetic peptide H1N1 vaccine is available now for testing worldwide, from Replikins Ltd. The company has developed the vaccine based on the same Replikins peptide technology which provided the surprise advance warning one year ago that the current H1N1 outbreak/pandemic was on its way (http://www.replikins.com/). A unique advantage of the Replikins vaccine is its [...]
May 9 2009 | Posted in
General,
Health,
U.S. |
Read More »